| Literature DB >> 27081513 |
John D Kriesel1, Amiteshwar Bhatia1, Alun Thomas2.
Abstract
Our group has recently described a gene on human chromosome 21, the Cold Sore Susceptibility Gene-1 (CSSG-1, also known as C21orf91), which may confer susceptibility to frequent cold sores in humans. We present here a genotype-phenotype analysis of CSSG-1 in a new, unrelated human population. Seven hundred fifty-eight human subjects were enrolled in a case/control Cold Sore Study. CSSG-1 genotyping, herpes simplex virus 1 (HSV1) serotyping, demographic and phenotypic data was available from 622 analyzed subjects. Six major alleles (H1-H6) were tested for associations with each of the self-reported phenotypes. The statistical analysis was adjusted for age, sex and ethnicity. Genotype-phenotype associations were analyzed from 388 HSV1-seropositive subjects. There were significant CSSG-1 haplotype effects on annual cold sore outbreaks (P=0.006), lifetime cold sores (P=0.012) and perceived cold sore severity (P=0.012). There were relatively consistent trends toward protection from frequent and severe cold sores among those with the H3 or H5/6 haplotypes, whereas those with H1, H2, and H4 haplotypes tended to have more frequent and more severe episodes. Different alleles of the newly described gene CSSG-1 affect the expression of cold sore phenotypes in this new, unrelated human population, confirming the findings of the previous family-based study.Entities:
Year: 2014 PMID: 27081513 PMCID: PMC4785534 DOI: 10.1038/hgv.2014.24
Source DB: PubMed Journal: Hum Genome Var ISSN: 2054-345X
Figure 1Cold sore susceptibility gene-1 (CSSG-1) map. The CSSG-1 gene spans 30,300 bp of chromosome 21. It is transcribed from the minus strand (for convenience shown left to right in this figure). Arrows indicate the locations of the six single-nucleotide polymorphisms (SNPs) within the gene. Each SNP is labeled with its wild-type nucleotide, rs (reference SNP) number and location within the gene. The two non-synonymous (amino-acid changing) SNPs are shown, D136E and N115K, both within exon 3. One SNP, rs2824499, used previously, is no longer considered here.[11]
Determination of the CSSG-1 haplotypes and their frequencies
|
| |||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| H1 | G | C (N) | C (D) | C | T | A | 278 (22) |
| H2 | G | C (N) |
|
| T |
| 427 (34) |
| H3 | G | C (N) | C (D) | C | T |
| 174 (14) |
| H4 | G |
| C (D) | C |
| A | 265 (21) |
| H5 |
| C (N) | C (D) | C |
| A | 83 (7) |
| H6 | G | C (N) | C (D) | C |
| A | 17 (1) |
A. The CSSG-1 haplotypes were determined using the PLINK computer application. Haplotype assignments are equivalent to those derived from the familial population previously published.[11] Changes from the ancestral form of the gene (wild type) H1 are shown in bold. B. Haplotype frequencies among the 370 HSV1-seropositive participants, contributing 740 haplotypes, are shown. Thirty-six-seropositive individuals reported some cold sores but <2 per year, making them of unknown or intermediate phenotype.
Abbreviations: CSSG-1,cold sore susceptibility gene-1; UTR, untranslated region.
Summary of the regression analyses for the three cold sore serostatus phenotypes (N=622 subjects)
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Effect size | −1.102 | 0.226 | 0.093 | 0.044 | 0.142 | 0.003 | −0.062 | 0.492 |
| Conventional s.e. | 0.222 | 0.128 | 0.183 | 0.006 | 0.164 | 0.205 | 0.181 | 0.264 |
| Conventional |
| 0.078 | 0.611 |
| 0.387 | 0.99 | 0.73 | 0.062 |
| Bootstrap s.e. | 0.304 | 0.183 | 0.271 | 0.008 | 0.164 | 0.213 | 0.182 | 0.256 |
| Bootstrap |
| 0.207 | 0.723 |
| 0.385 | 0.987 | 0.734 |
|
|
| ||||||||
| Effect size | −1.253 | 0.225 | 0.216 | 0.044 | 0.065 | −0.096 | −0.16 | 0.317 |
| Conventional s.e. | 0.217 | 0.126 | 0.181 | 0.005 | 0.161 | 0.202 | 0.179 | 0.253 |
| Conventional |
| 0.074 | 0.232 |
| 0.689 | 0.634 | 0.371 | 0.21 |
| Bootstrap s.e. | 0.296 | 0.179 | 0.27 | 0.008 | 0.162 | 0.21 | 0.177 | 0.248 |
| Bootstrap |
| 0.2 | 0.403 |
| 0.69 | 0.644 | 0.363 | 0.191 |
|
| ||||||||
| Effect size | 1.933 | 0.387 | 0.11 | 0.083 | 0.196 | 0.122 | −0.357 | 0.672 |
| Conventional s.e. | 0.432 | 0.256 | 0.37 | 0.01 | 0.33 | 0.415 | 0.368 | 0.5 |
| Conventional |
| 0.131 | 0.766 |
| 0.552 | 0.769 | 0.331 | 0.179 |
| Bootstrap s.e. | 0.567 | 0.359 | 0.512 | 0.013 | 0.335 | 0.44 | 0.363 | 0.475 |
| Bootstrap |
| 0.281 | 0.834 |
| 0.559 | 0.784 | 0.323 | 0.161 |
Subjects were defined as HSV1 seropositive if the EI was >1.1 (manufacturer’s recommendation) or EI >2.5 (more stringent definition). The regression analysis was also performed on the continuous variable of EI. Significant values are in bold.
Abbreviations: EI, enzyme-linked immunosorbent assay index; Hap, haplotype.
Summary of the regression analyses for four herpes disease phenotypes (N=388 HSV1-seropositive subjects)
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Effect size | 0.955 | −0.614 | −0.786 | 0.013 | −0.203 | −0.531 | −0.194 | −0.616 |
| Conventional s.e. | 0.312 | 0.167 | 0.232 | 0.007 | 0.234 | 0.280 | 0.264 | 0.318 |
| Conventional |
|
|
| 0.059 | 0.385 | 0.058 | 0.463 | 0.053 |
| Bootstrap s.e. | 0.413 | 0.242 | 0.340 | 0.010 | 0.228 | 0.271 | 0.243 | 0.319 |
| Bootstrap |
|
|
| 0.164 | 0.362 | 0.050 | 0.417 | 0.056 |
|
| ||||||||
| Effect size | 5.277 | −1.598 | −1.827 | −0.026 | 0.380 | −1.110 | 0.758 | −1.014 |
| Conventional s.e. | 0.708 | 0.401 | 0.591 | 0.015 | 0.525 | 0.664 | 0.598 | 0.753 |
| Conventional |
|
|
| 0.086 | 0.470 | 0.095 | 0.205 | 0.178 |
| Bootstrap s.e. | 0.979 | 0.490 | 0.626 | 0.022 | 0.501 | 0.408 | 0.692 | 0.449 |
| Bootstrap |
|
|
| 0.200 | 0.451 |
| 0.263 |
|
|
| ||||||||
| Effect size | 31.847 | −37.739 | −15.763 | 1.890 | 5.211 | −28.389 | 0.768 | −25.107 |
| Conventional s.e. | 15.299 | 8.663 | 12.780 | 0.330 | 11.343 | 14.354 | 12.913 | 16.267 |
| Conventional |
|
| 0.218 |
| 0.646 |
| 0.953 | 0.123 |
| Bootstrap s.e. | 19.811 | 10.654 | 23.411 | 0.496 | 11.410 | 11.353 | 13.137 | 12.765 |
| Bootstrap | 0.105 |
| 0.471 |
| 0.654 |
| 0.957 | 0.050 |
|
| ||||||||
| Effect size | 1.738 | −0.465 | −0.396 | 0.001 | −0.208 | −0.344 | −0.110 | −0.238 |
| Conventional s.e. | 0.143 | 0.081 | 0.119 | 0.003 | 0.106 | 0.134 | 0.121 | 0.152 |
| Conventional |
|
|
| 0.797 | 0.050 |
| 0.361 | 0.118 |
| Bootstrap s.e. | 0.191 | 0.113 | 0.172 | 0.004 | 0.103 | 0.130 | 0.112 | 0.163 |
| Bootstrap |
|
|
| 0.847 |
|
| 0.330 | 0.150 |
The regression analysis was also performed on the discrete variable ‘affection status’ and the continuous variables ‘annual outbreaks’, ‘lifetime outbreaks’, and ‘perceived severity’. Significant values are in bold.
Abbreviation: Hap, haplotype.
Figure 2Self-reported annual cold sore outbreaks among the 622 analyzed subjects. The bimodal distribution of HSV1-seropositive (EI >1.1) subjects was due to recruitment and enrollment of only clearly ‘affected’ and ‘unaffected’ individuals.